- Constituents: Yale School of Medicine
- Type of Cancer Center: Clinical and Research
Yale Cancer Center (YCC) was founded in 1974 as a result of an act of Congress in 1971, which declared the nation's "war on cancer." It is one of a select network of 41 NCI-designated Cancer Centers throughout the country, designated by the National Cancer Institute (NCI), and the only one in southern New England. Directed by Thomas J. Lynch, Jr., MD, the Cancer Center brings together the resources of the Yale School of Medicine (YSM), Yale-New Haven Hospital (YNHH), the Yale School of Public Health (YSPH), and Yale University.
Over sixty years ago, the faculty at Yale School of Medicine pioneered the modern concepts of chemotherapy by administering the very first anticancer agent, nitrogen mustard, to a patient with cancer. Today, scientists and clinicians at Yale Cancer Center are collaborating to design and develop the latest cancer treatments and combination therapy to patients in Phase I, II, and III clinical trials.
Since the passage of the National Cancer Act in 1972, the NCI has mandated that comprehensive cancer centers, like Yale, develop fundamental basic science that translates into innovative therapies for cancer patients.
Cancer patients at Yale are able to directly